← FDA DRUG APPROVALS

FDA ANDA · ANDA040352

MEPERIDINE HYDROCHLORIDE

Sponsor: SPECGX LLC

APPLICATION
ANDA040352
TYPE
ANDA
ORIGINAL APPROVAL
2000-06-13
LATEST ACTION
2023-12-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEPERIDINE HYDROCHLORIDEDiscontinued
MEPERIDINE HYDROCHLORIDE 100MG · TABLET · ORAL
MEPERIDINE HYDROCHLORIDEDiscontinued
MEPERIDINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2023-12-15Labeling · Supplement 6 · standardAP
2018-09-18REMS · Supplement 5AP
2005-11-03Labeling · Supplement 4AP
2000-06-13OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →